Last reviewed · How we verify
NCT06075186
Secondary Victim Awareness of Anesthesiologists
trial testing A survey to assess anesthesiologists' secondary victim experience and quality of support resources. in Questionnaire in 200 participants. Status unknown.
30 November 2023
Quick facts
| Lead sponsor | Selcuk University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 April 2023 |
| Primary completion | 30 November 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- A survey to assess anesthesiologists' secondary victim experience and quality of support resources.
Conditions studied
- Questionnaire — all drugs for Questionnaire →
Sponsor
Selcuk University
Who can join
Adults 25 to 65, any sex, with Questionnaire. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Every professional working in the medical field may encounter medical errors and patient safety issues during their careers. Wu, et al. He coined the term 'second victim', which was used for the first time in 2000. In a patient safety incident, the patient is the first to be affected, while the second to be affected are the healthcare professionals (physicians, assistants, nurses, and medical staff) who are the potential causes of the incident and who are adversely affected by the consequences of this incident. That is, secondary victims are characterized as healthcare professionals who are involved in unexpected adverse patient events and experience occupational or psychological difficulties. Almost half of healthcare professionals have been reported to experience the second victim phenomenon during their professional careers. Medical errors or adverse events can deeply affect healthcare professionals and have long-term effects, leading to permanent consequences. In the medical field, identifying the origins of errors plays a vital role in preventing future errors. Second victims can encourage constructive change by not only criticizing the healthcare system but also contributing to the improvement of healthcare institutions. Burlison and his team developed and validated a tool they called the "Second Victim Experience and Support Tool" (SVEST) to understand the coping process of second victims and identify necessary support resources. Koca and colleagues conducted a validation study of the translation and psychometric evaluation of the SVEST (T-SVEST) in Turkey. Our study aims to evaluate the secondary victim experience of anesthesiologists and the quality of support resources.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06075186
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Selcuk University trials
Trials by the same sponsor.
- NCT07402499 — Validation of a Virtual Reality Timed Up and Go Test in Adults With Chronic Non-Specific Low Back Pain · not yet recruiting
- NCT07364591 — Immediate Effect of Kinesiotaping With Rounded Shoulder Posture in University Students · NA · not yet recruiting
- NCT07381244 — Validity, Reliability, and Clinical Correlates of Immersive Virtual Reality Adaptation of the Five Times Sit-to-stand Te · not yet recruiting
- NCT07373704 — Respiratory Muscle Strength and Endurance Cut-Offs in Multiple Sclerosis · not yet recruiting
- NCT07362368 — Virtual Reality-Based Five-Repetition Sit-to-Stand Test in Young Adults · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06075186 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Selcuk University
- Last refreshed: 10 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06075186.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing